Trhová kapitalizácia spoločnosti Amgen
Aká je hodnota metriky Trhová kapitalizácia spoločnosti Amgen?
Hodnota metriky Trhová kapitalizácia spoločnosti Amgen, Inc. je $144.23B
Aká je definícia metriky Trhová kapitalizácia?
Trhová kapitalizácia (Market cap) je trhová hodnota vydaných akcií obchodovanej spoločnosti a je rovná cene akcie v danom čase vynásobenej počtom kusov vydaných akcií.
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Trhová kapitalizácia spoločností v sektore Health Care sektor na XETRA v porovnaní so spoločnosťou Amgen
Čomu sa venuje spoločnosť Amgen?
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and a strategic research and development collaboration with Neumora Therapeutics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Firmy s metrikou trhová kapitalizácia podobnou spoločnosti Amgen
- Hodnota metriky Trhová kapitalizácia spoločnosti PetroChina Co je $140.56B
- Hodnota metriky Trhová kapitalizácia spoločnosti Sberbank of Russia je $140.89B
- Hodnota metriky Trhová kapitalizácia spoločnosti Agricultural Bank of China je $141.50B
- Hodnota metriky Trhová kapitalizácia spoločnosti ConocoPhillips je $142.46B
- Hodnota metriky Trhová kapitalizácia spoločnosti Meituan Dianping je $143.59B
- Hodnota metriky Trhová kapitalizácia spoločnosti Honeywell International je $143.88B
- Hodnota metriky Trhová kapitalizácia spoločnosti Amgen je $144.23B
- Hodnota metriky Trhová kapitalizácia spoločnosti Honeywell International Inc je $144.36B
- Hodnota metriky Trhová kapitalizácia spoločnosti Raytheon Tech. ,01 je $144.44B
- Hodnota metriky Trhová kapitalizácia spoločnosti Meituan Dianping je $145.46B
- Hodnota metriky Trhová kapitalizácia spoločnosti Charles Schwab je $146.99B
- Hodnota metriky Trhová kapitalizácia spoločnosti RTX Corp je $147.42B
- Hodnota metriky Trhová kapitalizácia spoločnosti Comcast je $148.13B